Home >> Top News >> FDA-cleared Inova Dx calprotectin test

FDA-cleared Inova Dx calprotectin test

Print Friendly, PDF & Email

Jan. 8, 2018Inova Diagnostics announced the clearance of Quanta Flash Calprotectin by the FDA. Quanta Flash Calprotectin aids in the diagnosis of inflammatory bowel disease and helps differentiate IBD from irritable bowel syndrome. The assay provides precise quantification, with an analytical measurement range of up to 3,500 mg/kg, is available on Bio-Flash, a random access chemiluminescent instrument, and can be run simultaneously with other Quanta Flash assays. It is the first fully automated, random access calprotectin assay available in the U.S.

More top news


Check Also

Inova launches next-gen EIA/IFA processor, 3/18

March 2018—Inova Diagnostics announced the launch of its Quanta-Lyser 3000, a fully automated enzyme-linked immunoassay and immunofluorescence assay processor for use in clinical laboratories.